HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Derek LeRoith Selected Research

Lipids

1/2022Distinct Lipidomic Signatures in People Living With HIV: Combined Analysis of ACTG 5260s and MACS/WIHS.
1/2020Obesity, Type 2 Diabetes, and Cancer Risk.
10/2017Hexarelin, a Growth Hormone Secretagogue, Improves Lipid Metabolic Aberrations in Nonobese Insulin-Resistant Male MKR Mice.
10/2016Metabolic syndrome and pre-diabetes contribute to racial disparities in breast cancer outcomes: hypothesis and proposed pathways.
12/2015Ovariectomy is associated with metabolic impairments and enhanced mammary tumor growth in MKR mice.
5/2013Post-transcriptional activation of PPAR alpha by KLF6 in hepatic steatosis.
1/2007Dyslipidemia and glucose dysregulation in overweight and obese patients.
10/2004Muscle-specific overexpression of CD36 reverses the insulin resistance and diabetes of MKR mice.
7/2003Peroxisome proliferator-activated receptor-alpha agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Derek LeRoith Research Topics

Disease

58Neoplasms (Cancer)
01/2023 - 02/2002
41Type 2 Diabetes Mellitus (MODY)
10/2021 - 10/2002
36Insulin Resistance
01/2022 - 10/2002
31Breast Neoplasms (Breast Cancer)
01/2023 - 08/2003
21Hyperinsulinism (Hyperinsulinemia)
01/2019 - 11/2004
20Obesity
10/2021 - 12/2006
15Hyperglycemia
01/2023 - 10/2002
8Neoplasm Metastasis (Metastasis)
01/2022 - 02/2002
7Dyslipidemias (Dyslipidemia)
11/2018 - 11/2004
6Inflammation (Inflammations)
01/2023 - 03/2005
4Hypoglycemia (Reactive Hypoglycemia)
07/2023 - 06/2003
4Hypercholesterolemia
01/2023 - 12/2015
4Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2023 - 11/2007
4Lung Neoplasms (Lung Cancer)
11/2021 - 02/2002
4Triple Negative Breast Neoplasms
01/2021 - 10/2014
4Carcinogenesis
04/2018 - 09/2010
4Body Weight (Weight, Body)
10/2017 - 02/2011
3Diabetes Mellitus
01/2023 - 02/2004
3Sepsis (Septicemia)
01/2023 - 01/2017
2Cognitive Dysfunction
01/2020 - 10/2015
2Autoimmune Diseases (Autoimmune Disease)
01/2019 - 07/2015
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
06/2016 - 07/2015
2Carcinoma (Carcinomatosis)
09/2015 - 05/2013
2Colorectal Neoplasms (Colorectal Cancer)
02/2015 - 04/2008
2Fatty Liver
05/2013 - 11/2004
2Hyperplasia
06/2011 - 06/2003
2Hypertrophy
10/2010 - 11/2008
2Prostatic Neoplasms (Prostate Cancer)
03/2010 - 05/2008
2Osteosarcoma (Osteogenic Sarcoma)
05/2009 - 10/2003
2Adenocarcinoma
05/2008 - 02/2002
2Colonic Neoplasms (Colon Cancer)
04/2008 - 02/2002
2Starvation
12/2004 - 06/2004
1Chromosome Aberrations (Chromosome Abnormalities)
01/2022
1HIV Infections (HIV Infection)
01/2022
1Multiple Organ Failure (MODS)
01/2022

Drug/Important Bio-Agent (IBA)

44Insulin (Novolin)FDA Link
07/2023 - 10/2002
29Insulin-Like Growth Factor I (IGF-1)IBA
07/2015 - 02/2002
28Glucose (Dextrose)FDA LinkGeneric
10/2021 - 06/2003
15Insulin ReceptorIBA
12/2020 - 09/2005
14Insulin-Like PeptidesIBA
01/2022 - 06/2003
13IGF Type 1 Receptor (IGF 1 Receptor)IBA
10/2013 - 06/2003
9LipidsIBA
01/2022 - 07/2003
8CytokinesIBA
01/2022 - 11/2007
8Hormones (Hormone)IBA
01/2022 - 12/2006
8Metformin (Glucophage)FDA LinkGeneric
01/2022 - 04/2010
7AdipokinesIBA
01/2020 - 02/2011
6Blood Glucose (Blood Sugar)IBA
10/2021 - 01/2004
6Triglycerides (Triacylglycerol)IBA
10/2017 - 10/2003
5CholesterolIBA
01/2023 - 11/2004
5Proteins (Proteins, Gene)FDA Link
12/2021 - 10/2003
5Small Interfering RNA (siRNA)IBA
11/2019 - 06/2004
5Growth Hormone (Somatotropin)IBA
10/2017 - 10/2003
5Hypoglycemic Agents (Hypoglycemics)IBA
12/2016 - 09/2005
5Messenger RNA (mRNA)IBA
09/2015 - 10/2003
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2022 - 02/2002
4Estrogens (Estrogen)FDA Link
12/2020 - 12/2006
4Nonesterified Fatty Acids (NEFA)IBA
06/2019 - 10/2002
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016 - 02/2002
4Transcription Factors (Transcription Factor)IBA
01/2016 - 10/2003
4Tumor Viral Antigens (Large T Antigen)IBA
01/2016 - 08/2003
4Insulin-Like Growth Factor II (Somatomedin A)IBA
10/2014 - 06/2003
3LDL CholesterolIBA
01/2023 - 01/2018
3Estrogen ReceptorsIBA
09/2022 - 03/2012
3Somatomedin Receptors (Somatomedin Receptor)IBA
12/2020 - 12/2013
3ChemokinesIBA
01/2020 - 12/2013
3LeptinIBA
12/2013 - 09/2005
3CarbohydratesIBA
01/2012 - 11/2004
3Insulin-Like Growth Factor Binding Protein 3IBA
10/2003 - 09/2002
2Glucagon-Like Peptide 1 (GLP 1)IBA
01/2023 - 02/2009
2LDL Receptors (LDL Receptor)IBA
01/2023 - 01/2021
2Peptide Hormones (Polypeptide Hormones)IBA
01/2022 - 10/2012
2Cadherins (E-Cadherin)IBA
01/2022 - 01/2016
2Estradiol (Delestrogen)FDA LinkGeneric
12/2020 - 12/2015
2salicylhydroxamic acid (SHAM)IBA
01/2020 - 12/2015
2Interleukin-6 (Interleukin 6)IBA
11/2018 - 01/2016
2LigandsIBA
11/2018 - 02/2007
2Lysine (L-Lysine)FDA Link
04/2018 - 08/2006
2Arginine (L-Arginine)FDA Link
04/2018 - 08/2006
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2018 - 01/2007
2Insulin Glargine (Lantus)FDA Link
01/2017 - 01/2016
2Sirolimus (Rapamycin)FDA Link
12/2016 - 12/2010
2Advanced Glycation End ProductsIBA
04/2016 - 03/2005
2VimentinIBA
01/2016 - 06/2013
2disodium (R,R)- 5- (2- ((2- (3- chlorophenyl)- 2- hydroxyethyl)- amino)propyl)- 1,3- benzodioxole- 2,3- dicarboxylateIBA
01/2016 - 03/2010
2AdiponectinIBA
12/2013 - 08/2006
2SteroidsIBA
10/2012 - 12/2006
2Streptozocin (Streptozotocin)FDA Link
12/2004 - 06/2003
2PPAR alphaIBA
04/2004 - 07/2003
1Glucagon-Like Peptide-1 ReceptorIBA
07/2023
1oxidized low density lipoproteinIBA
01/2023
1Bromodeoxyuridine (BrdU)IBA
01/2023
1Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2023
1tyrosine receptor (receptor, tyrosine)IBA
01/2022
1Vasopressins (Vasopressin)IBA
01/2022
1Phosphotransferases (Kinase)IBA
01/2022
1Oxytocin (Pitocin)FDA LinkGeneric
01/2022

Therapy/Procedure

25Therapeutics
01/2023 - 03/2004
4Glycemic Control
10/2015 - 01/2007
3Drug Therapy (Chemotherapy)
12/2016 - 03/2004
1Art Therapy
01/2022